Bioactive lipids improve serum HDL and PON1 activities in coronary artery disease patients: Ex-vivo study.

Background: Atherosclerotic cardiovascular disease (CVD) remains a leading cause of vascular disease worldwide. Atherosclerosis is characterized by the accumulation of lipids and oxidized lipids on the blood vessel walls. Coronary artery disease (CAD) is the most common display of atherosclerotic CVD.